2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease

References

Page 1

	Year	Citations
The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes Mellitus New England Journal of Medicine	1993	24.5K
Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33) The Lancet Metabolic SyndromeDiabetes ManagementInsulin ManagementDiabetesType 2	1998	19.9K
Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin New England Journal of Medicine	2002	18.8K
2013 ACCF/AHA Guideline for the Management of Heart Failure Clyde W. Yancy, Mariell Jessup, Biykem Bozkurt, Journal of the American College of Cardiology Heart FailureCardiovascular DiseasePatient SafetyCardiac CareMedicine	2013	12.6K
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes Bernard Zinman, Christoph Wanner, John M. Lachin, New England Journal of Medicine	2015	11.6K
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR) European Heart Journal Vascular DiseaseCardiometabolic RiskEuropean GuidelinesUnstable AnginaPreventive Cardiology	2012	8.5K
Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) The Lancet ObesityMetabolic SyndromeDiabetes ManagementCardiovascular DiseaseUkpds 34	1998	8.2K
Effect of physical inactivity on major non-communicable diseases worldwide: an analysis of burden of disease and life expectancy I‐Min Lee, Eric J. Shiroma, Felipe Lobelo, The Lancet Physical ActivityPreventive MedicineHealth EffectGlobal HealthChronic Disease	2012	8K
Effects of Intensive Glucose Lowering in Type 2 Diabetes New England Journal of Medicine	2008	7.8K
Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes Bruce Neal, Vlado Perkovic, Kenneth W. Mahaffey, New England Journal of Medicine	2017	7.5K

Page 1